Scientists from Sydney IVF and the Australian Stem Cell Centre (ASCC) in Melbourne have launched a project to characterise and compare induced pluripotent stem cells, human embryonic stem cells and stem cells derived from somatic cell nuclear transfer.
The aim of the project is to develop a routine, repeatable way of making patient-specific stem cells within current legislative guidelines.
The NSW Minister for Science and Medical Research, Verity Firth, and the Victorian Minister for Innovation, Gavin Jennings, made the announcement today at the BIO 2008 convention in San Diego.
Each government has pledged $550,000 to the project. NSW will fund Sydney IVF to undertake the SCNT work, while Victoria has funded the ASCC to perform the characterisation and comparison of the stem cells.
The ASCC recently announced it was the first international group to import iPS cells, licensing them from Professor James Thomson at the University of Wisconsin. Thomson described the development of iPS cells in one of two ground-breaking papers in November last year.
"The combination of the international quality talent and significant resources of these two collaborative partners gives this project the potential to provide world-first advancements in these new biological frontiers," Firth said.
Firth, on her first trip to BIO since becoming a minister 18 months ago, said the project was a collaboration not only between scientists but between governments.
"We have real excellence in stem cell research both in NSW and Victoria," she said. "One thing you learn at BIO is that we are Australia here - it's a bit silly for the states to compete."
No comments:
Post a Comment